Consensus Valerio Therapeutics

Equities

ALVIO

FR0010095596

Real-time Euronext Paris Other stock markets 09:41:38 2024-04-29 am EDT			5-day change	1st Jan Change
0.1114 ^EUR	+1.27%		-4.13%	-32.48%

2023	Valerio Therapeutics Société anonyme Reports Earnings Results for the Half Year Ended June 30, 2023	CI
2023	Onxeo SA has Changed its Name to Valerio Therapeutics	CI

Evolution of the average Target Price on Valerio Therapeutics

Price target over the last 5 years

History of analyst recommendation changes

eb0f32d8e7cc4aea8e8534.1c8__ELY0KI65CGhO9l6DQMFG2oH4KnjVIiaXa9-TqI.uLV4kxf1m9JUiWvLY4YXWS4oWQlgpZmgEsvuOfcJedu6hmjIFommlnK8FQ~13c692b2d7258b7b13c97cd7ec3705aa

Analyst Recommendations on Valerio Therapeutics

Onxeo : Bryan Garnier & Co initiates the coverage of Onxeo with a “Buy” recommendation	20-05-29	PU
Bryan Garnier & Co Initiates Coverage of Onxeo with a “Buy” Recommendation	20-05-27	GL
Onxeo : Bryan Garnier & Co Initiates the Coverage of Onxeo with a “Buy” Recommendation	20-05-27	BU

More recommendations

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

0.11 EUR

Average target price

1.2 EUR

Spread / Average Target

+990.91%

High Price Target

1.2 EUR

Spread / Highest target

+990.91%

Low Price Target

1.2 EUR

Spread / Lowest Target

+990.91%

Consensus detail

Consensus revision (last 18 months)

Annual profits - Rate of surprise

Company calendar